Satellos Bioscience Inc. (MSCLF)
USD 0.62
(-0.06%)
USD 0.62
(-0.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.5 Million | -5.71 Million | -5.03 Million | -1.65 Million | -2.23 Million | -1.1 Million |
| Net Income | -15.88 Million | -11.32 Million | -15.5 Million | -1.57 Million | -1.93 Million | -1.7 Million |
| Depreciation & Amortization | 7000.00 | 336.94 Thousand | 165.68 Thousand | 422.00 | -3063.00 | -1538.00 |
| Deferred income taxes | - | - | -19.77 Thousand | 6973.00 | 5608.69 | - |
| Stock-based compensation | 2.16 Million | 1.44 Million | 971.53 Thousand | 88.6 Thousand | 37.44 Thousand | - |
| Change in working capital | 369 Thousand | 991.73 Thousand | -485.63 Thousand | -182.92 Thousand | -302.43 Thousand | 595.59 Thousand |
| Other non-cash items | -1.15 Million | 2.84 Million | 9.84 Million | 5470.00 | 479.86 Thousand | 990.00 |
| Investing Cash Flow | -17.53 Million | -3469.00 | 1.73 Million | - | -5992.00 | -3196.00 |
| Investments in PPE | -18 Thousand | -3469.00 | -7246.00 | - | -5992.00 | -3196.00 |
| Acquisitions | - | - | 1.74 Million | - | - | - |
| Investment purchases | -17.52 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -17.52 Thousand | - | 1.74 Million | - | - | - |
| Financing Cash Flow | 51.03 Million | 2.77 Million | 7.45 Million | 1.97 Million | 3.21 Million | - |
| Debt repayment | -2.52 Million | - | -186.57 Thousand | -1.08 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 32.46 Million | 1.99 Million | 7.07 Million | 890.54 Thousand | 3.21 Million | - |
| Other Financing Activities | 603 Thousand | 778.75 Thousand | 558.6 Thousand | 2.17 Million | 1.15 Million | - |
| Accounts receivables | -323 Thousand | 1783.00 | 40.12 Thousand | -29.4 Thousand | -284.18 Thousand | -41.35 Thousand |
| Accounts payables | - | 726.11 Thousand | -390.47 Thousand | -444.85 Thousand | - | - |
| Inventory | - | -726.11 Thousand | 390.47 Thousand | 444.85 Thousand | - | - |
| Other working capital | 369 Thousand | 989.94 Thousand | -525.76 Thousand | -153.51 Thousand | -18.24 Thousand | 636.94 Thousand |
| Cash at beginning of period | 1.92 Million | 4.87 Million | 717.53 Thousand | 399.12 Thousand | - | - |
| Cash at end of period | 22.06 Million | 1.92 Million | 4.87 Million | 717.53 Thousand | 399.12 Thousand | -1.1 Million |
| Capital Expenditure | -18 Thousand | -3469.00 | -7246.00 | - | -5992.00 | -3196.00 |
| Effect of forex changes on cash | 1.14 Million | -5823.00 | -1444.00 | - | -973.36 Thousand | - |
| Net cash flow / Change in cash | 20.14 Million | -2.94 Million | 4.15 Million | 318.4 Thousand | 399.12 Thousand | -1.1 Million |
| Free Cash Flow | -14.51 Million | -5.71 Million | -5.04 Million | -1.65 Million | -2.24 Million | -1.1 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.03 Million | -6.9 Million | -15.88 Million | -6.53 Million | -3.57 Million | -4.11 Million |
| Depreciation & Amortization | 3000.00 | 2000.00 | 7000.00 | 2000.00 | 2687.00 | 1278.00 |
| Deferred income taxes | - | - | - | - | - | 1.18 Million |
| Stock-based compensation | 693 Thousand | 736 Thousand | 2.16 Million | 854 Thousand | 744.69 Thousand | 369.3 Thousand |
| Change in working capital | -134 Thousand | -253 Thousand | 369 Thousand | 1.05 Million | 415.43 Thousand | -1.37 Million |
| Other non-cash items | 91.00 | 857.00 | -1.15 Million | -816 Thousand | -1.58 Million | 48.51 Thousand |
| Investing Cash Flow | 2.35 Million | -2.1 Million | -17.53 Million | -17.52 Million | -10.13 Thousand | -6867.00 |
| Investments in PPE | -4000.00 | -2000.00 | -18 Thousand | -1000.00 | -10.13 Thousand | -6867.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -2.09 Million | -17.52 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2357.00 | -2098.00 | -17.52 Thousand | -17.52 Million | - | - |
| Financing Cash Flow | 16 Thousand | - | 51.03 Million | - | -2.01 Million | 50.8 Million |
| Debt repayment | - | - | -2.52 Million | - | -284 Thousand | -140.53 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 32.46 Million | -2.68 Million | 390.00 | 50.8 Million |
| Other Financing Activities | 16.00 | - | 603 Thousand | 2.68 Million | -1.73 Million | 50.66 Thousand |
| Accounts receivables | -109 Thousand | - | - | - | 2956.00 | -293.94 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -410.00 | -373.00 | 369 Thousand | 1.05 Million | 412.47 Thousand | -1.08 Million |
| Cash at beginning of period | 13.11 Million | 22.06 Million | 1.92 Million | 44.26 Million | 48.72 Million | 2.98 Million |
| Cash at end of period | 9.83 Million | 13.11 Million | 22.06 Million | 22.06 Million | 44.26 Million | 48.72 Million |
| Capital Expenditure | -4000.00 | -2000.00 | -18 Thousand | -1000.00 | -10.13 Thousand | -6867.00 |
| Effect of forex changes on cash | 6000.00 | 278 Thousand | 1.14 Million | 761 Thousand | 1.56 Million | -1.17 Million |
| Net cash flow / Change in cash | -3.28 Million | -8.95 Million | 20.14 Million | -22.19 Million | -4.46 Million | 45.74 Million |
| Free Cash Flow | -5.66 Million | -7.13 Million | -14.51 Million | -5.43 Million | -4 Million | -3.89 Million |
ASMTEC
6906
5271
CHGCF
SDMHF
0R2P